Dis-Chem, a leading South African retail and healthcare group, is leveraging strategic investments to strengthen its position in the evolving healthcare and wellness market.

Despite persistent consumer affordability pressures in its 2026 financial year, the company remains well-positioned to capitalize on growing demand for accessible healthcare solutions.

Chairman Larry Nestadt emphasized that the broader operating environment remains challenging, but the group's integrated healthcare ecosystem, trusted brand, and national footprint provide a solid foundation for future growth.

CEO Luis Morais highlighted key initiatives driving expansion, including the maturing of the Better Rewards programme, the launch of the Dis-Chem app, and the expansion of omnichannel capabilities.Investments in the X, bigly labs ecosystem, data analytics, and AI platforms are contributing to diversification and operational efficiency.The company also reported significant market share gains across retail categories, with 316 pharmacy stores and 193 TLC franchise clinics.

While short-term earnings were impacted by front-loaded investments, the board remains focused on sustainable growth, prudent financial management, and shareholder value.

Dis-Chem's wholesale division, serving over 1,600 independent pharmacies, further solidifies its role as a critical enabler within South Africa's healthcare ecosystem.